返回
Lymphoblastic lymphoma
DOI:10.1016/j.critrevonc.2017.03.020.png)
摘要
En 中文
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. Although histological features are usually sufficient to distinguish lymphoblastic from mature B- or T-cell neoplasms, of greater importance for diagnosis is the characterization of immunophenotype by flow cytometry. LBL occurs more commonly in children than in adults, mostly in males. A bone marrow involvement <25% (or 20% according to WHO) formally distinguishes LBL from ALL. The prognosis of LBL has dramatically improved with the use of intensive ALL-type chemotherapy regimens, which includes intensive intrathecal chemotherapy prophylaxis and consolidation with mediastinal irradiation. Patients with adverse prognostic features assessed by postinduction CT/positron emission tomography scans (PET) and minimal residual disease analysis (MRD) should be considered for high-dose chemotherapy and stem cell transplantation. Further therapeutic progresses are expected from the introduction of new drugs and targeting agents. (C) 2017 Elsevier B.V. All rights reserved.
Keyword:
Lymphoblastic lymphoma
Autologous stem-cell transplant
Allogeneic transplant
CNS prophylaxis
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
C
IF:
5.6
论文数:
4.4K
被引数:
1.2W
机构
引用论文
Economic benefits of sharing and redistributing influenza vaccines when shortages occurred
PLOS ONE
IF0
Preparation of high positioning accuracy lattice patterns with polymeric microfibers derived from near‐field electrospinning基于近场静电纺丝制备的高定位精度点阵图案用聚合物微纤维
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
ANNALS OF ONCOLOGY
IF65.4

